These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 1877870)
1. [A new approach to the search for antineoplastic compounds]. Nikitina ET; Aĭtkhozhina NA; Esenova ShSh Antibiot Khimioter; 1991 Mar; 36(3):20-4. PubMed ID: 1877870 [TBL] [Abstract][Full Text] [Related]
2. [The effect of a black tea extract on the tumor-like growth of the fungus Fusarium bulbigenum var. blasticola]. Zhemaletdinov FG Vopr Onkol; 1990; 36(2):192-6. PubMed ID: 2316201 [TBL] [Abstract][Full Text] [Related]
3. [Influence of antitumor preparations on the concentration of free radicals in cells of Fusarium bulbigenum var. blasticola fungus during primary and tumour-like secondary growth]. Riabikin IuA; Nikitina ET; Balgimbatva AS; Zashkvara OV; Shakiev SSh Biofizika; 2007; 52(2):306-13. PubMed ID: 17477059 [TBL] [Abstract][Full Text] [Related]
4. [Effect of antioxidants, pro-oxidants, respiration inhibitors and substrates on the formation of autonomic secondary colonies of Fusarium bulbigenum var. blasticola]. Zhemaletdinov FG; Liu BN Mikrobiologiia; 1987; 56(3):387-92. PubMed ID: 3657615 [TBL] [Abstract][Full Text] [Related]
5. [Induction of tumor-like growth in a culture of mycelial fungi--a potential experimental model of multistage carcinogenesis]. Zhemaletdinov FG; Kabiev OK; Balmukhanov SB Vopr Onkol; 1988; 34(8):960-6. PubMed ID: 3420839 [TBL] [Abstract][Full Text] [Related]
6. [Inhibiting effect of hypoxia on the development of tumor-like formations in the fungus Fusarium bulbigenum var. blasticola]. Akhtiamov MG; Zhemaletdinov FG; Karimov MA Eksp Onkol; 1986; 8(6):63-6. PubMed ID: 3803288 [TBL] [Abstract][Full Text] [Related]
7. The relationship between inhibitors of eukaryotic and prokaryotic serine proteases. Konaklieva MI; Plotkin BJ Mini Rev Med Chem; 2004 Sep; 4(7):721-39. PubMed ID: 15379640 [TBL] [Abstract][Full Text] [Related]
8. [Variability of mycelial microorganisms in space flight]. Aĭtkhozhina NA; Mitichkin OV; Aubakirov TO Prikl Biokhim Mikrobiol; 1994; 30(3):420-4. PubMed ID: 8047537 [TBL] [Abstract][Full Text] [Related]
9. [Result of antineoplastic agents screening: 7th report]. Gan To Kagaku Ryoho; 1998 Mar; 25 Suppl 2():147-392. PubMed ID: 9551093 [No Abstract] [Full Text] [Related]
10. Magnesium and cell cycle control: an update. Walker GM Magnesium; 1986; 5(1):9-23. PubMed ID: 3515058 [TBL] [Abstract][Full Text] [Related]
11. Piplartine induces genotoxicity in eukaryotic but not in prokaryotic model systems. Bezerra DP; Vasconcellos MC; Machado MS; Villela IV; Rosa RM; Moura DJ; Pessoa C; Moraes MO; Silveira ER; Lima MA; Aquino NC; Henriques JA; Saffi J; Costa-Lotufo LV Mutat Res; 2009; 677(1-2):8-13. PubMed ID: 19379832 [TBL] [Abstract][Full Text] [Related]
12. [Effect of anthracycline antibiotics on the cellular proliferation of human breast cancer heterografts growing in diffusion chambers in vivo]. Batomunkueva TV; Korman DB; Krutova TV Izv Akad Nauk SSSR Biol; 1989; (2):184-90. PubMed ID: 2745857 [TBL] [Abstract][Full Text] [Related]
13. Increased susceptibility of transfected prokaryotic and eukaryotic cells to antibiotic selection. Asselbergs FA; van Someren P Antimicrob Agents Chemother; 1992 Aug; 36(8):1782-4. PubMed ID: 1416866 [TBL] [Abstract][Full Text] [Related]
14. Fusaristatins A and B, two new cyclic lipopeptides from an endophytic Fusarium sp. Shiono Y; Tsuchinari M; Shimanuki K; Miyajima T; Murayama T; Koseki T; Laatsch H; Funakoshi T; Takanami K; Suzuki K J Antibiot (Tokyo); 2007 May; 60(5):309-16. PubMed ID: 17551209 [TBL] [Abstract][Full Text] [Related]
15. [Mechanism of action of the antineoplastic antibiotic asterin on cellular factors of immunogenesis regulation]. Smirnov VV; Mishenkova EL Antibiot Khimioter; 1994; 39(9-10):49-53. PubMed ID: 7695451 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of some anthracycline antibiotics in an in vivo model for studying drug-induced human leukemia cell differentiation. Schwartz EL; Brown BJ; Nierenburg M; Marsh JC; Sartorelli AC Cancer Res; 1983 Jun; 43(6):2725-30. PubMed ID: 6573951 [TBL] [Abstract][Full Text] [Related]
18. A predictive screening model for in vitro selection of agents with potential antitumor activity. Nocentini G; Barzi A Arzneimittelforschung; 1995 Dec; 45(12):1306-11. PubMed ID: 8595090 [TBL] [Abstract][Full Text] [Related]
19. Screening with COMPARE analysis for telomerase inhibitors. Naasani I; Yamori T; Tsuruo T Methods Mol Biol; 2002; 191():197-207. PubMed ID: 11951607 [No Abstract] [Full Text] [Related]
20. Single stranded DNA-vectors for analyzing processing of DNA damage induced by 4-nitroquinoline-1-oxide in prokaryotes and eukaryotes. Iannone R; Campomenosi P; Madzak C; Inga A; Caocci F; Abbondandolo A; Fronza G; Sarasin A Boll Soc Ital Biol Sper; 1992 Oct; 68(10):619-24. PubMed ID: 1295517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]